Essity

Transaction in Own Shares • Jan 5, 2026

Press release

Stockholm, January 5, 2026

Buyback of Class B shares in Essity during week 1, 2026

Between December 29, 2025, and January 2, 2026, Essity Aktiebolag (publ) repurchased a total of 42,073 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors.

The share purchase is part of the SEK 3bn buyback program announced by Essity on April 23, 2025. The buyback program will extend from April 24, 2025, until the 2026 Annual General Meeting and be implemented in accordance with the EU Market Abuse Regulation (MAR) and the European Commission's Delegated Regulation 2016/1052 (Safe Harbour Regulation).

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation.

Class B shares in Essity were repurchased as follows:

Date	Aggregated daily volume (no. of shares):	Weighted average price per day (SEK):	Total daily transaction value (SEK):
December 29, 2025	14,037	263.6822	3,701,307
December 30, 2025	14,330	264.7771	3,794,256
December 31, 2025	-	-	-
January 1, 2026	-	-	-
January 2, 2026	13,706	262.5037	3,597,876
Total accumulated during week 1 2026	42,073	263.6712	11,093,439
Total accumulated during the buyback program	9,237,032	258.4630	2,387,431,031

All purchases were conducted on Nasdaq Stockholm by BofA Securities Europe SA on behalf of Essity. Following the above purchases, Essity's holding of treasury shares amounted on January 2, 2026, to 10,019,532 Class B shares. The total number of shares in Essity amounted on the date of this press release to 693,054,489, of which 58,200,658 Class A shares and 634,853,831 Class B shares.

For additional information, please contact:

Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com

About Essity

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2024, Essity had net sales of approximately SEK 146bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.